Compare AUDC & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUDC | PRQR |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | Israel | Netherlands |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.7M | 262.5M |
| IPO Year | 2000 | 2014 |
| Metric | AUDC | PRQR |
|---|---|---|
| Price | $9.97 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.50 | $7.25 |
| AVG Volume (30 Days) | 109.3K | ★ 777.2K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.24 | N/A |
| Revenue Next Year | $2.18 | $13.92 |
| P/E Ratio | $23.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.95 | $1.33 |
| 52 Week High | $10.86 | $3.10 |
| Indicator | AUDC | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 60.62 |
| Support Level | $8.36 | $1.94 |
| Resistance Level | $10.31 | $1.99 |
| Average True Range (ATR) | 0.41 | 0.10 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 51.67 | 95.31 |
AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.